A group of six friends and family members is trekking 158 miles from Hessle to the Lake District to raise funds for Bowel Cancer UK and support Jon Metcalfe, a 46-year-old pub landlord diagnosed with terminal bowel cancer. The “Walk of all Walks,” scheduled for July 2026, aims to highlight Mr. Metcalfe’s campaign to lower the NHS bowel cancer screening age from 50 to 45.
Why is the bowel cancer screening age under scrutiny?
Jon Metcalfe, who operates The Butchers Arms in Crosby Ravensworth, advocates for lowering the national screening age to 45 following his own diagnosis. According to Mr. Metcalfe, he experienced no symptoms until he developed stomach pain that was initially mistaken for appendicitis. Medical tests later confirmed a bowel tumour that had metastasized to his liver and lymph nodes. Mr. Metcalfe states that if screening had occurred at age 45, his prognosis might have been significantly different. Data cited by Mr. Metcalfe indicates that bowel cancer cases in individuals under 50 have risen by 50% since the 1990s.
How are the walkers preparing for the 158-mile route?
The walking group, led by cousins Pete Bloor, 51, and Nick Bloor, 38, includes Marc Hartley, 39, Thomas O’Brian, 41, Lee Hall, 48, and Mark Hogben, 63. The team, supported by Barry Bloor in a campervan, plans to traverse a route passing through Wetherby, Ilkley, Buckden, and Ravenstondale. According to Nick Bloor, the group consists of working family men rather than professional athletes, making the physical toll of consecutive walking days a significant challenge. The team has been conducting practice walks to build endurance for the six-day journey.
What is the goal of the fundraising effort?
The initiative has already raised £2,500 via a GoFundMe page, with proceeds designated for Bowel Cancer UK and Cancer Research UK. Mr. Metcalfe is organizing a welcome party at The Butchers Arms on July 24, 2026, to celebrate the group’s arrival. The event has transitioned from a raffle to an auction due to the high value of donated prizes, which include a sailing trip in Scotland and a week-long stay at a French Alps chalet. Mr. Metcalfe noted that interest in the event grew to the point where the venue had to be moved to a local village hall to accommodate the expected attendance.
Frequently Asked Questions
- What is the current NHS bowel cancer screening age? In the UK, routine bowel cancer screening is typically offered to individuals aged 50 and over, though policies are subject to periodic review by health authorities.
- How can I support the “Walk of all Walks”? Supporters can donate via the team’s GoFundMe page or contact Nick Bloor at nicholas.bloor@icloud.com to offer logistical assistance, such as camping space.
- When is the final event taking place? The group is scheduled to complete their 158-mile journey on July 24, 2026, with a fundraising welcome party held at The Butchers Arms.
Support the cause: If you would like to follow the group’s progress or contribute to their fundraising goal, please visit their official GoFundMe page or follow their journey on YouTube.
- Alberta Keeps $100 COVID-19 Vaccine Fee Ahead of Fall Flu Campaign
- Social Media Driving Misuse of Alzheimer’s Blood Tests
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)